MRC says it will invent, develop, and market its own drugsBMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39215.852500.BE (Published 17 May 2007) Cite this as: BMJ 2007;334:1025
- Michael Day
The UK Medical Research Council (MRC) will step up its clinical research activities, after indicating that it expects a generous share of the increase in the research budget announced by the Treasury in March.
The council's chief executive, Colin Blakemore, said that government funded clinical trials were imminent, thanks to the increased funding.
This year's comprehensive spending review by the government announced an above inflation rise of 2.7% a year until 2011 in the budget for the research councils. Exactly how much the MRC receives will not be announced until the autumn.
However, when asked if the MRC was expecting a generous proportion of the increase, the MRC's chairman, John Chisholm, said, grinning: “I would have to say that …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial